NEW YORK (GenomeWeb News) — Waters will provide mass spectrometry equipment and training to the clinical research services company Lambda Therapeutics Research when Lambda lands service contracts, a Waters spokesman told GenomeWeb Daily News today.
 
The agreement  “paves the way” for Ahmedabad, India-based Lambda to purchase Waters’ Quattro Premier XE tandem quadrupole mass spectrometer, Acquity UPLC system, and MassLynx software for use in analyzing complex biological samples, Waters spokesman Jeff Tarmy said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.